ORIGINAL ARTICLESRISE AND FALL OF ASTHMA MORTALITY IN ENGLAND AND WALES IN RELATION TO USE OF PRESSURISED AEROSOLS
References (17)
Lancet
(1965)Lancet
(1965)Lancet
(1966)Med. J. Aust.
(1964)Med. J. Aust.
(1965)Paper presented to a joint meeting of the British Tuberculosis Association and the West of England Thoracic Society
(1966)- et al.
Br. med. J.
(1967) Aerosols in Asthma
Adverse Reactions Series
(1967)
There are more references available in the full text version of this article.
Cited by (273)
Disease-modifying anti-asthmatic drugs
2022, The LancetRepurposing drugs as inhaled therapies in asthma
2018, Advanced Drug Delivery ReviewsCitation Excerpt :In the early 1960s an aerosol formulation (100 μg) of isoprenaline was more widely marketed for personal use. Isoprenaline forte, a higher dose formulation (400 μg), was also marketed and sales of this appeared to be associated with an increase in deaths from asthma [45]. While no direct association was proven, the death rate fell when the over-the-counter sales of this formulation were stopped in the UK [45].
Pulmonary pharmacology
2018, Pharmacology and Physiology for Anesthesia: Foundations and Clinical ApplicationAre inhaled longacting β<inf>2</inf> agonists detrimental to asthma?
2013, The Lancet Respiratory MedicinePulmonary Pharmacology
2013, Pharmacology and Physiology for Anesthesia: Foundations and Clinical ApplicationHow will genetic approaches assist in the management of respiratory diseases?
2009, Current Opinion in Pharmacology
Copyright © 1969 Published by Elsevier Ltd.